Dr. John David Eatman M.D.

Recommended Articles

• Cardiac Magnetic Resonance Imaging: Helping Muscular Dystrophy Patients with Oedema-Fibrosis

  Duchenne muscular dystrophy (DMD) is a genetic muscular disorder that targets the muscles and causes them to degenerate and weaken. Statistically, around 15,000 males are affected by the condition in the U.S. alone and approximately 300,000 around the world [1]. The most common and severe form of a...

• The Impact Parkinson's Disease Has on Driving

  It may start with a tremor followed by muscle stiffness and a decrease range of movement but as Parkinson’s disease progresses so do its side effects. Aside from the well-known and more common symptoms of Parkinson’s disease, a positive diagnosis also means a whole slew of secondary symptoms...

• Breathlessness: Causes, Symptoms, and Treatment

  Introduction An unpleasant sensation of rapid breathing or difficulty breathing is known as breathlessness. People sometimes complain of feeling winded, puffed, or out of breath. Medically, it is called as dyspnea. Breathing may hurt and the person may feel tightness in the chest. It is normal to...

• Singing as therapy: how it helps people with Parkinson’s disease

  For a person diagnosed with Parkinson’s disease, their mobility and movement control ability is impaired, such that they will develop tremors. Moreover, getting dressed, eating, writing, brushing teeth, and driving becomes more challenging. Family members of a patient with Parkinson’s disease...

• Breakthrough in Parkinson's Disease Research Allows Patients to Sleep During Deep Brain Stimulation

  Deep brain stimulation surgery has contributed to an improvement to the quality of life for patients with Parkinson's disease. This brain surgery reduces the patient's symptoms and tremors by inserting electrodes into the brain. The catch? The patient is awake during the 4-6 hour surgery. Under...

• Targeting Enzyme May Be an Approach to Alzheimer’s Therapy

  Targeting particular enzymes to cure diseases or to relieve symptoms has never been an easy task. Indiscriminate targeting often results in unnecessary potentially toxic effects. For the same reasons, early attempts to target HDAC2 were not successful.Researchers knew that HDAC2 plays a vital role...